Continuum Labs LGD-4033 by Invisiblu International: Recall – Investigational Drug Not Approved for Use

ISSUE: Invisiblu International LLC is voluntarily recalling one lot of Continuum Labs LGD-Xtreme, 3 mg to the retail and consumer level. The product has been found to contain LGD-4033 Ligandrol, an investigational drug not approved for use. The risks of using this product are unknown.

The affected LGD-Xtreme lot numbers are 21511166 with expiration dates of 11/2018.

BACKGROUND: LGD-Xtreme is marketed as a dietary supplement to promote gains of lean muscle mass. The product is packaged in a dark amber plastic bottle with ninety capsules. The product can be identified by its black label with gold trim and the Continuum Labs logo. LGD-Xtreme was sold to select end consumers in the United States via the Internet, and was exported to wholesalers in Brazil.

RECOMMENDATION: Invisiblu International LLC is asking anyone in possession of this product to stop using and discard any unused capsules.

Click here to read the MedWatch safety alert, including a link to the press release; click here to see the full press release.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!